Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research

This publication has 19 references indexed in Scilit:

• Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy
  European Journal of Paediatric Neurology, 2002
• 75th European Neuromuscular Centre International Workshop: 2nd Workshop on the Treatment of Muscular Dystrophy 10–12 December, 1999, Naarden, The Netherlands
  Neuromuscular Disorders, 2000
• Modulation by prednisolone of calcium handling in skeletal muscle cells
  British Journal of Pharmacology, 1995
• Steroids in Duchenne muscular dystrophy; Pilot study of a new low-dosage schedule
  Neuromuscular Disorders, 1993
• Prednisolone enhances myogenesis and dystrophin‐related protein in skeletal muscle cell cultures from mdx mouse
  Journal of Neuroscience Research, 1993
• Long‐term benefit from prednisone therapy in Duchenne muscular dystrophy
  Neurology, 1991
• Glucocorticoids and immunosup pressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles
  Muscle & Nerve, 1991
• Dystrophin expression and somatic reversion in prednisone‐treated and untreated Duchenne dystrophy
  Neurology, 1991
• Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
  New England Journal of Medicine, 1989
• Dexamethasone Effects on Myoblast Proliferation and Differentiation*
  Endocrinology, 1980